Andrew Aronsohn is an Associate Professor of Medicine in the Center for Liver Diseases at the University of Chicago Medical Center and is the Chief of Hepatology as well as the program director for the Gastroenterology fellowship at the University of Chicago. Dr. Aronsohn is the co-principal investigator of HepCCATT, an initiative to diagnose, link to care and treat HCV in the Chicago area. This project utilizes telehealth technology to expand HCV management into the primary care setting. In addition, Dr. Aronsohn is a co-chair of the AASLD / IDSA HCV guidance and was a member of National Academies of Medicine committee which wrote “A National Strategy for the Elimination of Hepatitis B and C”. He also has a busy clinical practice, which includes both general and transplant hepatology.